Singapore Markets close in 39 mins

Biotech and Drug Stocks

Biotech and Drug Stocks

5.57k followers31 symbols Watchlist by Yahoo Finance

Follow this list to discover and track large drug and biotechnology companies.

Curated by Yahoo Finance

Follow this list to discover and track large drug and biotechnology companies. These companies develop specialty drugs and treatments for various diseases and medical conditions. Although there are risks associated with the success of the drug, those that succeed tend to have a strong series of earnings growth over a period of time, especially when they are backed by patents.

The list includes stocks priced at $5 or more with a three month average daily trading volume in excess of 200,000 shares. This list is generated daily and sorted by market cap; the gains are based on the latest closing price and limited to the top 30 stocks that meet the criteria.

This watchlist is similar to a discontinued watchlist called Battling Cancer.


Yahoo Finance employs sophisticated algorithms to monitor and detect trends in the Global Financial Markets. We bring these insights to you in the form of watchlists.

Find other winning investment ideas with the Yahoo Finance Screener.

How are these weighted?

The stocks in this watchlist are weighted equally.


WatchlistChange today1-month return1-year returnTotal return
Biotech and Drug Stocks+0.48%---

31 symbols

SymbolCompany nameLast priceChange% changeMarket timeVolumeAvg vol (3-month)Market cap
JNJJohnson & Johnson167.84-0.92-0.55%4:00 pm GMT-55.85M7.47M441.86B
RHHBYRoche Holding AG50.3+0.82+1.66%3:59 pm GMT-52.23M751.03k347.59B
PFEPfizer Inc.54.95-0.59-1.06%4:02 pm GMT-527.07M42.70M308.43B
ABBVAbbVie Inc.135.87+2.35+1.76%4:02 pm GMT-510.48M6.39M240.20B
LLYEli Lilly and Company244.12-5.55-2.22%4:02 pm GMT-52.89M3.07M233.52B
NVONovo Nordisk A/S96.32-3.24-3.25%4:00 pm GMT-52.46M1.21M219.57B
MRKMerck & Co., Inc.81.38+0.06+0.07%4:02 pm GMT-59.48M13.78M205.56B
NVSNovartis AG90.55-0.07-0.08%4:00 pm GMT-51.58M2.44M202.90B
AZNAstraZeneca PLC58.85+0.75+1.29%4:00 pm GMT-55.01M4.54M182.36B
BMYBristol-Myers Squibb Company64.93+0.33+0.51%4:00 pm GMT-510.30M13.07M144.12B
AMGNAmgen Inc.235.36+4.51+1.95%4:00 pm GMT-53.01M2.78M132.57B
SNYSanofi51.93+1.20+2.37%4:00 pm GMT-51.98M1.58M130.53B
GSKGlaxoSmithKline plc45.47+0.41+0.91%4:00 pm GMT-53.40M4.02M114.40B
ZTSZoetis Inc.206.18-0.82-0.40%4:03 pm GMT-52.21M1.66M97.55B
GILDGilead Sciences, Inc.71.77-0.11-0.15%4:00 pm GMT-58.34M7.15M90.03B
MRNAModerna, Inc.204.73-5.44-2.59%4:00 pm GMT-510.17M11.56M83.01B
REGNRegeneron Pharmaceuticals, Inc.615.24-0.87-0.14%4:00 pm GMT-5791.99k754.19k66.16B
BAYRYBayer Aktiengesellschaft15.06+0.53+3.65%3:59 pm GMT-5556.45k588.69k59.61B
VRTXVertex Pharmaceuticals Incorporated234.06+7.48+3.30%4:00 pm GMT-52.18M1.88M59.51B
WXXWYWuXi Biologics (Cayman) Inc.23.97+0.80+3.45%3:56 pm GMT-5138.22k226.44k50.96B
BNTXBioNTech SE196-6.99-3.44%4:00 pm GMT-52.86M3.34M47.53B
TAKTakeda Pharmaceutical Company Limited14.75+0.19+1.30%4:00 pm GMT-52.15M2.54M45.95B
BIIBBiogen Inc.239.3+2.63+1.11%4:00 pm GMT-51.77M1.58M35.15B
BGNEBeiGene, Ltd.238.64+2.46+1.04%4:00 pm GMT-5213.33k256.68k25.35B
SGENSeagen Inc.137.09+0.30+0.22%4:00 pm GMT-5811.33k810.77k25.07B
GMABGenmab A/S35.7+0.84+2.41%4:00 pm GMT-5626.36k433.77k23.48B
HZNPHorizon Therapeutics Public Limited Company91.1+0.70+0.77%4:00 pm GMT-52.61M1.57M20.66B
CTLTCatalent, Inc.108.24-1.74-1.58%4:03 pm GMT-51.29M1.06M18.53B
VTRSViatris Inc.15.22+0.20+1.33%4:00 pm GMT-55.77M10.20M18.41B
ALNYAlnylam Pharmaceuticals, Inc.148.5+0.50+0.34%4:00 pm GMT-5457.13k798.58k17.76B
  • Reuters

    UPDATE 1-Unilever says GSK consumer arm 'strong strategic fit' for business

    Dove soap maker Unilever signalled on Monday it would pursue a deal for GlaxoSmithKline's consumer health business, calling it a "strong strategic fit" after its 50-billion-pound approach ($68.4 billion) was rejected. The update comes after GSK confirmed over the weekend that it had rejected the Unilever offer for its consumer healthcare business, which is home to brands such as Sensodyne toothpaste and Emergen-C vitamin supplement. "The acquisition would create scale and a growth platform for the combined portfolio in the U.S., China and India, with further opportunities in other emerging markets," Unilever said, pointing to synergies in the oral care and vitamin supplements business.

  • Reuters

    UPDATE 1-Ahead of election, Macron banks on rosy French economy, new jobs

    President Emmanuel Macron will on Monday tout 21 new foreign investment projects in France and a booming economy as proof his economic reforms have been bearing fruit less than three months before a presidential election in which he is expected to run. During a visit to Alsace in the east, Macron will announce a 300-million-euro ($342 million) industrial project by German chemical giant BASF, one of 21 new projects worth 4 billion euros and 10,000 jobs as part of a drive to attract foreign investors, his office said. U.S. drugmaker Pfizer also announced on Monday a 520 million euros investment plan in France.

  • MarketWatch

    GSK rejects Unilever’s $68 billion takeover bid for consumer healthcare unit

    The pharmaceutical giant GlaxoSmithKline said Saturday it has rejected an unsolicited 50 billion-pound ($68.4 billion) bid from Unilever for its consumer healthcare goods unit, a joint venture it controls in a partnership with Pfizer.